1.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E1208, E1208, NCT01004978
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CRUK-TACE-2, TACE-2, 07130, UCL-07130, EU-21108, CRUK-HE3005, EUDRACT-2008-005073-36, CRUK-13136, ISRCTN-93375053, CTA-20363/0272/001, BAYER-CRUK-TACE-2, BIOCOM-UK-CRUK-TACE-2, NCT01324076
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HCC-P3-11-01, NCT01387932
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2012~A00269-34, NCT01676194
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SAKK 77/09, SWS-SAKK-77-09, SWS-SASL-30, EU-20986, CDR0000658353, NCT01009801
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Pereira-DE-2010, NCT01409733
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PRO08070016, NCT00877071
|
|
8.
|
Phase: Phase II Type: Health services research, Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BRD 10/6-M, NCT01300143
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and ove Sponsor: Other Protocol IDs: 2011/050, NCT01381211
|
|
10.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: G090097, NCT01010984
|
|
11.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 201108256, NCT01259024
|
|
12.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011LS117, NCT01489410
|